Skip Navigation HRSA - U.S Department of Health and Human Services, Health Resources and Service Administration HHS
Home
Questions
Order Publications
 
Grants Find Help Service Delivery Data Health Care Concerns About HRSA

Pharmacy Affairs & 340B Drug Pricing Program

ALERT: FDA Issues Public Health Advisory Regarding Levemir Insulin

Join the Collaborative now!
Patient Safety and Clinical Pharmacy Services Collaborative (PSPC 2.0)

A component of the Health Resources and Services Administration Healthcare Systems Bureau, the Office of Pharmacy Affairs has three primary functions:

  • Administration of the 340B Drug Pricing Program, through which certain federally funded grantees and other safety net health care providers may purchase prescription medication at significantly reduced prices.
  • Development of innovative pharmacy services models and technical assistance.
  • Service as a federal resource about pharmacy.

In all of its activities, OPA emphasizes the importance of comprehensive pharmacy services being an integral part of primary health care.  Comprehensive pharmacy services include patient access to affordable pharmaceuticals, application of "best practices" and efficient pharmacy management and the application of systems that improve patient outcomes through safe and effective medication use.

Office of Pharmacy Affairs
5600 Fishers Lane,
Parklawn Building, Mail Stop 10C-03
Rockville, MD 20857


Current Issues Highlights
 

Amgen's Letter to OPA - pricing adjustments to PHS Pricing for three Vectibix® NDC Products (August 6, 2009)

340B Drug Pricing Program Flexibilities During Emergencies and Disaster (May 1, 2009)

HRSA issues Medicaid Exclusion Tutorial and Medicaid Exclusion File Basics - March 2008

HRSA Patient Safety & Clinical Pharmacy Services Collaborative February 2008

More Current Issues